期刊
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
卷 14, 期 1, 页码 23-32出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2007.10.008
关键词
endothelial cell; graft-versus-host disease; idiopathic pneumonia syndrome; veno-occlusive disease; thrombotic microangiopathy; hematopoietic stem cell transplantation; tumor necrosis factor-alpha; cytokines; inflammation; microvasculature
Over the last 25 years, allogeneic hematopoietic stem cell transplantation (HSCT) has been used increasingly as a curative treatment option for patients with hematologic and neoplastic diseases. Despite major advances in transplant immunology and improvements in supportive and critical care medicine, HSCT is still plagued by several life-threatening complications. As such, the establishment of effective therapeutic options for these complications will be crucial as increasing numbers of high-risk transplants are performed each year. This brief review will discuss the contribution of vascular endothelial cell activation and injury to inflammation and end-organ toxicity that occurs following allogeneic HSCT, and will highlight translational research efforts that have paved the way to the development of novel strategies to treat and prevent disease. Finally, we will discuss in detail the clinical manifestations and challenges encompassed by the syndrome of thrombotic microangiopathy following HSCT. (c) 2008 American Society for Blood and Marrow Transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据